Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters -- they're not just another dose of ...
The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines ... A third player in the market, Novavax, filed for approval of a non-mRNA vaccine ...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-Mâ„¢ adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the ...
Inovio Pharmaceuticals Inc.-3.56% $138.65M ...
A trial participant developed amytrophic lateral sclerosis (ALS), an event deemed unrelated to vaccination. Novavax’s shares jumped in pre-market trading on the news but settled once markets opened.
Analysts had expected a loss of US$753 million, or US$1.90 a share, according to LSEG data. Its Spikevax Covid vaccine brought in sales of US$1.8 billion, up 3.5 per cent over the previous year and ...
A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...